Login to Your Account

‘One Piece of this Puzzle’

Curemark Moves Toward Approval of First Autism Drug

By Brian Orelli
Contributing Writer

Monday, November 18, 2013

While some genes have been linked to autism spectrum disorder, the exact cause of the disease isn’t known. With a dearth of knowledge about the disease, there haven’t been any drugs specifically developed to treat autism, although Risperdal (risperidone, Johnson & Johnson) and Abilify (aripiprazole, Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd) are approved to treat irritability associated with autism.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription